Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Achondroplasia D000130 1 associated lipids
Acinetobacter Infections D000151 4 associated lipids
Acne Vulgaris D000152 35 associated lipids
Acquired Immunodeficiency Syndrome D000163 12 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Airway Obstruction D000402 13 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Dorrell L et al. Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease. 1994 Thorax pmid:8016806
Slater M et al. The impact of azithromycin therapy on the airway microbiota in asthma. 2014 Thorax pmid:24287164
Murphy DM et al. Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allografts. 2007 Thorax pmid:17726173
Brill SE et al. Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial. 2015 Thorax pmid:26179246
le Normand Y et al. [Software modeling for better understanding of pharmacokinetic-pharmacodynamic relationships: application to azithromycin in the treatment of streptococcal tonsillitis and in acute exacerbation fo chronic bronchitis]]. 2004 Jan-Feb Therapie pmid:15199685
Wilms EB et al. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis. 2006 Ther Drug Monit pmid:16628134
Fouda HG and Schneider RP Quantitative determination of the antibiotic azithromycin in human serum by high-performance liquid chromatography (HPLC)-atmospheric pressure chemical ionization mass spectrometry: correlation with a standard HPLC-electrochemical method. 1995 Ther Drug Monit pmid:7624907
Raines DA et al. Simultaneous high-performance liquid chromatography analysis of azithromycin and two of its metabolites in human tears and plasma. 1998 Ther Drug Monit pmid:9853988
Coeman M et al. Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study. 2011 Ther Adv Respir Dis pmid:21890536
Gage TW New drugs from 1991-1992. 1993 Tex Dent J pmid:8273018
Karpov OI et al. [Comparative trial of 3-day azithromycin versus 10-day coamoxilav course efficacy in acute sinusitis]. 1998 Ter. Arkh. pmid:9644751
MashkilleÄ­son AL [The treatment of early syphilis today]. 1996 Ter. Arkh. pmid:9045378
Khamitov RF et al. [Significance of antibacterial therapy of Chlamydophila pneumoniae infection in patients with bronchial asthma]. 2004 Ter. Arkh. pmid:15575487
Williams K Patient-delivered therapy: an additional means for addressing the Chlamydia trachomatis problem. 2002 Tenn Med pmid:12491815
Peng JY et al. Electrochemical behavior of azithromycin at graphene and ionic liquid composite film modified electrode. 2011 Talanta pmid:22063535
Luo Q et al. Surface plasmon resonance sensor for antibiotics detection based on photo-initiated polymerization molecularly imprinted array. 2016 Talanta pmid:27769483
Cone LA et al. Delirium in the elderly resulting from azithromycin therapy. 2003 Surg Neurol pmid:12826358
Semel ME et al. Babesiosis in the immediate postoperative period after splenectomy for trauma. 2009 Surg Infect (Larchmt) pmid:19622029
Hassan KS and Al-Khadouri G Pneumonia with Worsening Pleural Effusion Despite Treatment with Appropriate Antimicrobials: Case report. 2018 Sultan Qaboos Univ Med J pmid:30210860
Schlünzen F et al. Structural basis for the antibiotic activity of ketolides and azalides. 2003 Structure pmid:12623020
Schouten JT and Whittemore S Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC). 1996 STEP Perspect pmid:11364267
Chavada VD et al. Surface plasmon resonance based selective and sensitive colorimetric determination of azithromycin using unmodified silver nanoparticles in pharmaceuticals and human plasma. 2017 Spectrochim Acta A Mol Biomol Spectrosc pmid:27419643
Tan X et al. Study on the chemiluminescence behavior of bovine serum albumin with luminol and its analytical application. 2011 Spectrochim Acta A Mol Biomol Spectrosc pmid:21435942
Ashour S and Bayram R Novel spectrophotometric method for determination of some macrolide antibiotics in pharmaceutical formulations using 1,2-naphthoquinone-4-sulphonate. 2012 Spectrochim Acta A Mol Biomol Spectrosc pmid:23041925
Krudsood S et al. A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand. 2000 Southeast Asian J. Trop. Med. Public Health pmid:11414432
Na-Bangchang K et al. Activity of artemether-azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria. 1996 Southeast Asian J. Trop. Med. Public Health pmid:9185262
Chokephaibulkit K et al. Intestinal parasitic infections among human immunodeficiency virus-infected and -uninfected children hospitalized with diarrhea in Bangkok, Thailand. 2001 Southeast Asian J. Trop. Med. Public Health pmid:12041552
Choemunng A and Na-Bangchang K An alternative liquid chromatography-mass spectrometric method for the determination of azithromycin in human plasma and its application to pharmacokinetic study of patients with malaria. 2010 Southeast Asian J. Trop. Med. Public Health pmid:21073024
Supattanapong S and Konsil J Solid phase extraction and high performance liquid chromatography for the determination of azithromycin in human plasma. 2008 Southeast Asian J. Trop. Med. Public Health pmid:19062684
Krudsood S et al. A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. 2002 Southeast Asian J. Trop. Med. Public Health pmid:12693587
Ohnishi K et al. Treatment of Japanese patients with enteric fever using azithromycin and MIC levels for causative organisms. 2013 Southeast Asian J. Trop. Med. Public Health pmid:23682445
Yeo AE et al. Indirect inhibition by antibiotics of nucleotide and deoxynucleotide biosynthesis in Plasmodium falciparum. 1998 Southeast Asian J. Trop. Med. Public Health pmid:9740262
Waites K et al. In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment. 1997 South. Med. J. pmid:9191739
Oliva S et al. Successful treatment of widely disseminated acanthamoebiasis. 1999 South. Med. J. pmid:9932828
Barroso LF and Wispelwey B Donovanosis presenting as a pelvic mass mimicking ovarian cancer. 2009 South. Med. J. pmid:19077787
Maleszka R et al. Pulsed azithromycin treatment is as effective and safe as 2-week-longer daily doxycycline treatment of acne vulgaris: a randomized, double-blind, noninferiority study. 2011 Mar-Apr Skinmed pmid:21548512
Bernstein JM The farmer and the tractor. 2003 Mar-Apr Skinmed pmid:14673307
Rallis E et al. Mycobacterium marinum cutaneous infection with sporotrichoid distribution treated with azithromycin monotherapy. 2012 Jan-Feb Skinmed pmid:22324181
Hui CK Endogenous lipoid pneumonia associated with Legionella pneumophila serogroup 1. 2013 Singapore Med J pmid:23546039
Tan HH and Chan RK An open label comparative study of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in males and Chlamydia trachomatis cervicitis in female sex workers in an STD clinic in Singapore. 1999 Singapore Med J pmid:10572491
Phoon YW et al. Isolation of multidrug-resistant Salmonella in Singapore. 2015 Singapore Med J pmid:26311915
Niccolai LM et al. Behavioural sources of repeat Chlamydia trachomatis infections: importance of different sex partners. 2011 Sex Transm Infect pmid:21212380
Pasternack R et al. Follow up of treatment: an integral part of the control of Chlamydia trachomatis infections. 1999 Sex Transm Infect pmid:10448353
Domeika M et al. Chlamydia trachomatis infections in eastern Europe: legal aspects, epidemiology, diagnosis, and treatment. 2002 Sex Transm Infect pmid:12081171
Patrick DM et al. Heterosexual outbreak of infectious syphilis: epidemiological and ethnographic analysis and implications for control. 2002 Sex Transm Infect pmid:12083438
Björnelius E et al. macrolide resistance in Stockholm, Sweden. 2017 Sex Transm Infect pmid:27502694
Horner PJ Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy. 2012 Sex Transm Infect pmid:22416272
Bartelsman M et al. Comparison of two Gram stain point-of-care systems for urogenital gonorrhoea among high-risk patients: diagnostic accuracy and cost-effectiveness before and after changing the screening algorithm at an STI clinic in Amsterdam. 2014 Sex Transm Infect pmid:24860102
Fifer H et al. Gonorrhoea treatment position statement. 2015 Sex Transm Infect pmid:26195472
Rice LB Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae? 2015 Sex Transm Infect pmid:25926405